Articles by Philip E. Castle, MPH, PhD

1 2 3 4 5

Risks of CIN 2+, CIN 3+, and Cancer by Cytology and Human Papillomavirus Status: The Foundation of Risk-Based Cervical Screening Guidelines

Demarco, Maria; Lorey, Thomas S.; Fetterman, Barbara; More

Journal of Lower Genital Tract Disease. 21(4):261-267, October 2017.

Scale-Up of an Human Papillomavirus Testing Implementation Program in El Salvador

Cremer, Miriam; Maza, Mauricio; Alfaro, Karla; More

Journal of Lower Genital Tract Disease. 21(1):26-32, January 2017.

A Common Clinical Dilemma: Management of Abnormal Vaginal Cytology and Human Papillomavirus Test Results

Khan, Michelle J.; Massad, L. Stewart; Kinney, Walter; More

Journal of Lower Genital Tract Disease. 20(2):119-125, April 2016.

Introducing a High-Risk HPV DNA Test Into a Public Sector Screening Program in El Salvador

Cremer, Miriam L.; Maza, Mauricio; Alfaro, Karla M.; More

Journal of Lower Genital Tract Disease. 20(2):145-150, April 2016.

p16 Immunohistochemistry Interpretation by Nonpathologists as an Accurate Method for Diagnosing Cervical Precancer and Cancer

Liao, Guang-Dong; Kang, Le-Ni; Chen, Wen; More

Journal of Lower Genital Tract Disease. 19(3):207-211, July 2015.

The Influence of Human Papillomavirus Genotypes on Visual Screening and Diagnosis of Cervical Precancer and Cancer

Jeronimo, Jose; Bansil, Pooja; Valdez, Melissa; More

Journal of Lower Genital Tract Disease. 19(3):220-223, July 2015.

Cervical Cancer Rates After the Transition From Annual Pap to 3-Year HPV and Pap

Dinkelspiel, Helen; Fetterman, Barbara; Poitras, Nancy; More

Journal of Lower Genital Tract Disease. 18(1):57-60, January 2014.

Benchmarking CIN 3+ Risk as the Basis for Incorporating HPV and Pap Cotesting into Cervical Screening and Management Guidelines

Katki, Hormuzd A.; Schiffman, Mark; Castle, Philip E.; More

Journal of Lower Genital Tract Disease. 17:S28-S35, April 2013.

Five-Year Risks of CIN 3+ and Cervical Cancer Among Women With HPV Testing of ASC-US Pap Results

Katki, Hormuzd A.; Schiffman, Mark; Castle, Philip E.; More

Journal of Lower Genital Tract Disease. 17:S36-S42, April 2013.

Five-Year Risks of CIN 2+ and CIN 3+ Among Women With HPV-Positive and HPV-Negative LSIL Pap Results

Katki, Hormuzd A.; Schiffman, Mark; Castle, Philip E.; More

Journal of Lower Genital Tract Disease. 17:S43-S49, April 2013.

Five-Year Risks of CIN 3+ and Cervical Cancer Among Women With HPV-Positive and HPV-Negative High-Grade Pap Results

Katki, Hormuzd A.; Schiffman, Mark; Castle, Philip E.; More

Journal of Lower Genital Tract Disease. 17:S50-S55, April 2013.

Five-Year Risks of CIN 3+ and Cervical Cancer Among WomenWho Test Pap-Negative But Are HPV-Positive

Katki, Hormuzd A.; Schiffman, Mark; Castle, Philip E.; More

Journal of Lower Genital Tract Disease. 17:S56-S63, April 2013.

Five-Year Risk of CIN 3+ to Guide the Management of Women Aged 21 to 24 Years

Katki, Hormuzd A.; Schiffman, Mark; Castle, Philip E.; More

Journal of Lower Genital Tract Disease. 17:S64-S68, April 2013.

Follow-up Testing After Colposcopy: Five-Year Risk of CIN 2+ After a Colposcopic Diagnosis of CIN 1 or Less

Katki, Hormuzd A.; Gage, Julia C.; Schiffman, Mark; More

Journal of Lower Genital Tract Disease. 17:S69-S77, April 2013.

Five-Year Risk of Recurrence After Treatment of CIN 2, CIN 3, or AIS: Performance of HPV and Pap Cotesting in Posttreatment Management

Katki, Hormuzd A.; Schiffman, Mark; Castle, Philip E.; More

Journal of Lower Genital Tract Disease. 17:S78-S84, April 2013.

Comparative Risk of High-Grade Histopathology Diagnosis After a CIN 1 Finding in Endocervical Curettage Versus Cervical Biopsy

Gage, Julia C.; Duggan, Máire A.; Nation, Jill G.; More

Journal of Lower Genital Tract Disease. 17(2):137-141, April 2013.

American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early...

Saslow, Debbie; Solomon, Diane; Lawson, Herschel W.; More

Journal of Lower Genital Tract Disease. 16(3):175-204, July 2012.

Risk of Cervical Precancer and Cancer in Women Aged 30 Years and Older With an HPV-Negative Low-Grade Squamous Intraepithelial Lesion Screening Result

Littell, Ramey D.; Kinney, Walter; Fetterman, Barbara; More

Journal of Lower Genital Tract Disease. 15(1):54-59, January 2011.

Lessons From Practice: Risk of CIN 3 or Cancer Associated With an LSIL or HPV-Positive ASC-US Screening Result in Women Aged 21 to 24

Moore, Gaea; Fetterman, Barbara; Cox, J. Thomas; More

Journal of Lower Genital Tract Disease. 14(2):97-102, April 2010.

Risk Assessment to Guide the Prevention of Cervical Cancer

Castle, Philip E.; Sideri, Mario; Jeronimo, Jose; More

Journal of Lower Genital Tract Disease. 12(1):1-7, January 2008.

  • Spanish Translation

Performance of Direct Visual Inspection of the Cervix with Acetic Acid and Magnification in a Previously Screened Population

Rodríguez, Ana Cecilia; Morera, Lidia Ana; Bratti, Concepción; More

Journal of Lower Genital Tract Disease. 8(2):132-138, April 2004.

Right-Sided Ectocervical Lesions May Be Associated with False-Negative Cytology Among Women with Histologic Cervical Intraepithelial Neoplasia 2 or 3

Jeronimo, Jose; Castle, Philip E.; Herrero, Rolando; More

Journal of Lower Genital Tract Disease. 7(3):175-183, July 2003.

1 2 3 4 5